Cell No. : Cell Name RCB5704 : TMEM64 KO HeLa  update : 2024/05/07
Comment			Currently not ready.
Comment from the depositor			HeLa in which TMEM64 gene was deleted using CRISPR/Cas9-mediated genome editing.
Terms and conditions
Remarks			CRISPR/Cas9 genome edited bioresources Announcement of bioresources developed by the CRISPR/Cas9 technology.
Order Form
			Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
	Basic information	Expected time	Upon a request we will start preparation. Contact us: cellkitaku.brc@riken.jp
Reference information		Reference	1
		User's Publication	0

Top

Reference

17346  Okawa F, Hama Y, Zhang S, Morishita H, Yamamoto H, Levine TP, Mizushima N.  Evolution and insights into the structure and function of the DedA superfamily containing TMEM41B and VMP1  J Cell Sci  2021  34(8):jcs255877.  PubMed ID: 33771928   DOI: 10.1242/jcs.255877

Top

User's Publication